Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Bayer Healthcare to sue Abbott

Bayer Healthcare to sue Abbott

30th December 2008

Bayer Healthcare has filed a lawsuit against Abbott, accusing the latter of patent infringement.

The case centres around breach of copyright of an arthritis prescription drug and was initiated on December 24th.

According to the Tyler Morning Telegraph, It will see a lawsuit brought against Abbott Laboratories, Abbott Bioresearch Centre and Abbott Bio-technology.

The newspaper added the subsidiaries in question are accused of having knowledge of the patent – issued in 1997 – but still manufactured and marketed Humira, a human tremour necrosis factor alpha, used for treatment of arthritis and other conditions.

As a result of the case, Bayer is asking for monetary damages that arise from the infringement, along with any resulting interest and fees, the Daily Herald also noted.

Scott Stoffel, an Abbott spokesman, was quoted by the newspaper: “Humira does not infringe Bayer’s patent and Abbott believes that Bayer’s patent is invalid.

“We will vigorously defend against this lawsuit.”

Earlier this month, tests found Bayer Healthcare’s Xarelto reduced the risk of venous thromboembolism in patients who had knee or hip replacement surgery.

The drug – examined in the Record clinical trial programme – was found to lower the chance of the condition by more than 50 per cent, in comparison to Enoxaparin.

We currently have 5 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.